- Home
- FluxMPS™ Minimum Essential Medium (MEM), Low Glucose, NEAA w/o Sodium Pyruvate, Sodium Bicarbonate, Phenol Red: 1X Liquid
FluxMPS™ Minimum Essential Medium (MEM), Low Glucose, NEAA w/o Sodium Pyruvate, Sodium Bicarbonate, Phenol Red: 1X Liquid
FluxMPS™ DCP-MEM-PBR1X is a Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) MEM Low Glucose + NEAA formulation engineered for primary fibroblasts, neurons, epithelial, and vascular cell models on organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. The 0.04 µm final cut-off is five times finer than the 0.22 µm membranes used for conventional sterile filtration. NEAA is pre-loaded to reduce metabolic burden on primary cells. Formulation: [+] Earle's Salts, [+] NEAA, [+] Low Glucose (1000 mg/L), [+] L-Glutamine | [-] Sodium Pyruvate, [-] Sodium Bicarbonate, [-] Phenol Red.
- Low Glucose (1.0 g/L) — a physiological carbon source better tolerated by primary cells sensitive to high-glucose stress.
- NEAA pre-loaded — reduces de novo amino acid synthesis burden and ammonia accumulation in primary cell culture.
- Quadruple-stage filtration train: 0.1 µm prefiltration I → 0.04 µm final filtration I → 0.1 µm prefiltration II → 0.04 µm final filtration II, reaching a 0.04 µm final cut-off.
- Endotoxin release specification < 0.05 EU/mL (LAL, USP <85>) — a specification relevant to TLR4-sensitive primary fibroblast, neuronal, and epithelial cultures.
- Bicarbonate-free, phenol-red-free, CO₂-independent base — supplement with HEPES (15–25 mM) for pH buffering in open-chip or imaging workflows.
- Manufactured under an ISO 13485:2016 quality management system; final QC at Diagnocine, Totowa, NJ.
- MEM with Earle's Salts + NEAA is the established base for primary fibroblast, neuronal, epithelial and vascular cell models.
- pH, glucose concentration, salts, and nutrient composition available on request — contact support@diagnocine.com.
- Glucose1000 mg/L (1.0 g/L, Low Glucose)
- L-Glutamine292 mg/L (Present)
- Sodium PyruvateNot added
- pH (USP <791>)7.4
- Osmolality (USP <785>)235–275 mOsm/kg H2O
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2 (Quadruple-stage)
- Storage2–8°C, protected from light
- Shelf Life12 months from date of manufacture, unopened
- ShippingCold pack (gel packs), 2–8°C in transit
Engineered for primary cell culture where standard media fails
MEM with Earle's Salts is the primary cell biologist's medium — but conventional 0.22 µm filtered MEM passes mycoplasma-sized particles, subvisible particulates, and endotoxin that can alter primary cell phenotype. FluxMPS™ is built on a quadruple-stage filtration train while preserving the full Earle's Salts + NEAA nutritional profile primary fibroblasts, neurons, epithelial, and vascular cells depend on.
Microchannel-safe purity
0.04 µm final filtration with USP <788> (Method 1) particulate compliance helps prevent chip microchannel clogging in sub-100 µm geometries.
Total metabolic control
A defined Low Glucose (1.0 g/L) carbon source, with sodium pyruvate withheld, lets you set the exact carbon substrate profile for primary cells sensitive to high-glucose stress.
Ultrapure-grade water
Type 1 water (18.2 MΩ·cm) with controlled trace-metal and total organic carbon (TOC) content supports consistent primary cell performance lot to lot.
Low background for imaging
An ultra-low particulate baseline and phenol-red-free formulation support confocal, TEER sensor, and biosensor workflows on primary cell chips.
Rich, stable nutrient profile
Pre-loaded NEAA (20 amino acid components) and Eagle's vitamin complement, released per micro-batch lot, reduce de novo synthesis burden on primary cells.
Customization on demand
pH, glucose, HEPES concentration, and component modifications available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages — two dedicated prefilter + final-filter pairs — reaching a final 0.04 µm polish.
-
1
0.1 µm Prefiltration I
Removes large aggregates and cell debris; protects the first 0.04 µm cartridge.
-
2
0.04 µm Final filtration I
Retains sub-micron particulates and material in the mycoplasma size range (0.2–0.3 µm) that pass a standard 0.22 µm filter.
-
3
0.1 µm Prefiltration II
A second dedicated prefilter, protecting the second 0.04 µm cartridge.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter prior to aseptic fill & finish.
Performance vs. conventional media
A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration.
© Diagnocine® — DCP-MEM-PBR1X
Primary cell models and OoC applications
FluxMPS™ DCP-MEM-PBR1X is purpose-built for primary fibroblast, neuronal, epithelial and vascular cell models, with 0.04 µm filtration purity for microfluidic platform compatibility.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) ultra-filtered MPS Grade variant of this formulation is available on request for automated bioreactor and robotic liquid-handling systems.
- Total Particulate Exclusion: 0.01 µm filtration removes nanoparticulate aggregates beyond the 0.04 µm cut-off.
- Valve & Sensor Protection: Reduces micro-fouling risk in delicate chip geometries.
- Extended Perfusion Stability: Supports consistent nutrient delivery over long-duration culture.
Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.
Neuronal Chips & Brain-on-Chip
MEM + Earle’s Salts + NEAA + low glucose is a physiologically conservative base for primary cortical neurons, DRG neurons, and iPSC-derived neuronal networks in compartmentalized chips.
Epithelium-on-Chip
Low-glucose MEM with NEAA supports primary epithelial cells and barrier integrity in transwell and microfluidic TEER-monitored platforms.
Primary Fibroblast & Stromal Models
MEM with NEAA is a classical base for primary dermal, lung, and cardiac fibroblasts in low-serum or serum-free OoC conditions.
Vascular Cell Culture
Earle’s Salts ionic balance supports vascular smooth muscle cells and primary endothelial co-culture models on vascular-on-chip platforms.
Organ-on-a-Chip & MPS
0.04 µm filtered MEM helps prevent particulate accumulation in sub-100 µm neuronal and epithelial chip microchannels.
Microscopy & Optical Sensing
Low particulate baseline and a phenol-red-free formulation suit confocal, TEER sensor, and biosensor applications on primary cell chips.
Analytical release specifications
Every lot released against the full specification matrix. CoA: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] L-Glutamine, [+] Calcium, [+] Magnesium, [+] Glucose | [-] Sodium Bicarbonate, [-] Phenol Red, [-] Sodium Pyruvate |
| Media family | MEM Low Glucose + NEAA (Earle's Salts base) |
| Appearance | Pale yellow-colored, clear solution |
| Glucose | 1000 mg/L (1.0 g/L, Low Glucose) |
| NEAA | Present (20 amino acid components; see Full Composition) |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 235–275 mOsm/kg H2O |
| Total ingredients | 34 |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm / 0.04 µm barrier filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | NMT 25/mL |
| Particulate ≥25 µm USP <788> Method 1 | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, away from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO₂ requirement | CO₂-independent; supplement with HEPES (15–25 mM) for pH buffering |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
MEM Low Glucose + NEAA: 34 ingredients verified per lot with CAS numbers. NEAA is listed under AMINO ACIDS.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Magnesium sulfate anhydrous | 7487-88-9 | 97.720 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium chloride | 7647-14-5 | 6800.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 122.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| Glycine | 56-40-6 | 7.500 |
| L-Alanine | 56-41-7 | 8.900 |
| L-Arginine hydrochloride | 1119-34-2 | 126.000 |
| L-Asparagine monohydrate | 5794-13-8 | 15.000 |
| L-Aspartic acid | 56-84-8 | 13.300 |
| L-Cystine dihydrochloride | 30925-07-6 | 31.300 |
| L-Glutamic acid | 56-86-0 | 14.700 |
| L-Glutamine | 56-85-9 | 292.000 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 42.000 |
| L-Isoleucine | 73-32-5 | 52.000 |
| L-Leucine | 61-90-5 | 52.000 |
| L-Lysine hydrochloride | 657-27-2 | 72.500 |
| L-Methionine | 63-68-3 | 15.000 |
| L-Phenylalanine | 63-91-2 | 32.000 |
| L-Proline | 147-85-3 | 11.500 |
| L-Serine | 56-45-1 | 10.500 |
| L-Threonine | 72-19-5 | 48.000 |
| L-Tryptophan | 73-22-3 | 10.000 |
| L-Tyrosine disodium salt dihydrate | 69847-15-0 | 51.900 |
| L-Valine | 72-18-4 | 46.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 1.000 |
| D-Ca-Pantothenate | 137-08-6 | 1.000 |
| Folic acid | 59-30-3 | 1.000 |
| Nicotinamide | 98-92-0 | 1.000 |
| Pyridoxal hydrochloride | 65-22-5 | 1.000 |
| Riboflavin | 83-88-5 | 0.100 |
| Thiamine hydrochloride | 67-03-8 | 1.000 |
| OTHERS | ||
| i-Inositol | 87-89-8 | 2.000 |
| D-Glucose | 50-99-7 | 1000.000 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a multi-layer quality system.
ISO 13485:2016 Quality Management
Manufactured under an ISO 13485:2016–certified quality management system. Final QC at Diagnocine's R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
Type 1 water (18.2 MΩ·cm) with controlled trace-metal and total organic carbon (TOC) content.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch, per-lot tested — no blending; a Certificate of Analysis is issued for every lot.
Endotoxin — USP <85> BET
LAL assay; release specification < 0.05 EU/mL per batch.
Particulate — USP <788> Method 1
NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm); Light Obscuration Particle Count Test.
Osmolality — USP <785>
Target: 235–275 mOsm/kg H2O.
Documentation & CoA
Full CoA with raw-material traceability available for every lot on request.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-MEM-PBR1X compares
FluxMPS™ DCP-MEM-PBR1X vs. conventional 0.22 µm–filtered MEM Low Glucose + NEAA formulations. Rows without a published, attributable competitor figure are shown as "Not specified."
| Parameter | DCP-MEM-PBR1X (FluxMPS™) | Conventional MEM Low Glucose (0.22 µm filtered) |
Standard DMEM (0.22 µm) |
|---|---|---|---|
| Grade | Microfluidics Suitable | Not specified | Not specified |
| Low Glucose MEM + NEAA, without Pyruvate/Bicarbonate/Phenol Red | check_circle Yes | Not specified | Not specified |
| Final filtration pore size | 0.04 µm | Not specified | Not specified |
| Number of filtration stages | 4 (Quadruple-stage) | Not specified | Not specified |
| Mycoplasma barrier filtration | check_circle Yes (0.1/0.04 µm barrier stages) | Not specified | Not specified |
| Endotoxin (release specification) | < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP <788> particulate tested | check_circle Yes | Not specified | Not specified |
| Water quality | Type 1, 18.2 MΩ·cm | Not specified | Not specified |
| Manufacturing QMS | ISO 13485:2016 | Not specified | Not specified |
| Microfluidic channel compatible | check_circle Yes | Not specified | Not specified |
| Custom formulation available | check_circle Yes | Not specified | Not specified |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified."
Frequently asked questions
Common questions about FluxMPS™ DCP-MEM-PBR1X.
Supporting literature
Key publications supporting MEM Low Glucose + NEAA in primary cell OoC applications.
- Eagle H. Amino acid metabolism in mammalian cell cultures. Science. 1959;130:432–437. doi:10.1126/science.130.3373.432
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
- Campisi M, et al. 3D self-organized microvascular model of the human blood-brain barrier. Biomaterials. 2018;180:117–129. doi:10.1016/j.biomaterials.2018.07.014
- Jang KJ, et al. Human kidney proximal tubule-on-a-chip. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
- Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
- Sung JH, et al. Microfabricated mammalian organ systems. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j
